Testing effectiveness (Phase 2)Active Not RecruitingNCT03366844What this trial is testingBreast Cancer Study of Preoperative Pembrolizumab + RadiationWho this might be right forBreast Cancer Stephen Shiao 66
Testing effectiveness (Phase 2)Looking for participantsNCT06452394What this trial is testingNEODOXy: Targeting Breast Cancer Stem Cells With DoxycyclineWho this might be right forBreast Cancer Swiss Cancer Institute 50
Testing effectiveness (Phase 2)Looking for participantsNCT06062498What this trial is testingElacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast CancerWho this might be right forEstrogen-receptor-positive Breast CancerHER2/Neu-Negative Breast CancerAdvanced Breast Cancerv+1 more Northwestern University 174
Early research (Phase 1)Study completedNCT03554044What this trial is testingT-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast CancerWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+11 more University of California, San Francisco 20
Large-scale testing (Phase 3)Study completedNCT00785291What this trial is testingPaclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast CancerWho this might be right forEstrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+6 more National Cancer Institute (NCI) 799
Testing effectiveness (Phase 2)WithdrawnNCT01612910What this trial is testingOral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and SurgeryWho this might be right forBreast Cancer Female Barbara Ann Karmanos Cancer Institute
Not applicableLooking for participantsNCT06805812What this trial is testingPredicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 StudyWho this might be right forBreast AdenocarcinomaBreast Cancer Stage IVBreast Cancer, Metastatic+38 more Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 3,500
Testing effectiveness (Phase 2)Study completedNCT02536742What this trial is testingPalbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer ETOP IBCSG Partners Foundation 124
Large-scale testing (Phase 3)Study completedNCT00630032What this trial is testingSafety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast CancerWho this might be right forBreast Cancer UNICANCER 762
Early research (Phase 1)WithdrawnNCT04498520What this trial is testingAbexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic CancerWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more Pamela Munster
Not applicableLooking for participantsNCT03723928What this trial is testingS1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor PositiveHER2/Neu Negative+3 more SWOG Cancer Research Network 739
Testing effectiveness (Phase 2)Study completedNCT01750073What this trial is testingPaclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast CancerWho this might be right forEstrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+13 more University of Nebraska 92
Testing effectiveness (Phase 2)Study completedNCT02536794What this trial is testingMEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast CancerWho this might be right forEstrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+2 more Northwestern University 30
Testing effectiveness (Phase 2)Ended earlyNCT04738292What this trial is testingOnapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)Who this might be right forER-positive Breast CancerHER2-negative Breast CancerMetastatic Cancer University of Wisconsin, Madison 11
Testing effectiveness (Phase 2)Ended earlyNCT01477060What this trial is testingModulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Fondazione Michelangelo 32
Not applicableStudy completedNCT03961880What this trial is testingImpact of Recurrence Score on Adjuvant Treatment Decisions in Breast Cancer PatientsWho this might be right forBreast Cancer Female University Hospital Tuebingen 270
Testing effectiveness (Phase 2)Looking for participantsNCT04965766What this trial is testingPatritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast CancerWho this might be right forMetastatic Breast CancerAdvanced Breast Cancer Gustave Roussy, Cancer Campus, Grand Paris 139
Testing effectiveness (Phase 2)Study completedNCT03106077What this trial is testingMirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast CancerWho this might be right forAnatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+18 more M.D. Anderson Cancer Center 96
Large-scale testing (Phase 3)Temporarily pausedNCT06671912What this trial is testingTesting Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialWho this might be right forAnatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage 1 Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8+4 more Alliance for Clinical Trials in Oncology 1,556
Early research (Phase 1)Study completedNCT02586675What this trial is testingTEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast CancerWho this might be right forBreast CancerBreast Cancer - FemaleBreast Cancer - Male H. Lee Moffitt Cancer Center and Research Institute 7